Tourmaline Bio, Inc.
TRML
Revenue
0.00
0.000.00%
-Assets
344.79M
▼-14.38M▼-4.00%
3 Months ChangeLiabilities
6.51M
▲1.48M▲29.40%
3 Months ChangeFree Cash Flow
-14.92M
▼-11.11M▼-291.17%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-10
Form 8-K
ID: 0001827506-24-000086
2024-09-11
Form 8-K
ID: 0001827506-24-000083
2024-09-05
Form 8-K
ID: 0001827506-24-000078
2024-08-08
Form 10-Q
ID: 0001827506-24-000072
2024-08-08
Form 8-K
ID: 0001827506-24-000070
2024-06-27
Form 8-K
ID: 0001827506-24-000061
2024-06-07
Form 8-K
ID: 0001827506-24-000057
2024-05-13
Form 10-Q
ID: 0001827506-24-000036
2024-05-13
Form 8-K
ID: 0001827506-24-000032
2024-03-19
Form 8-K
ID: 0001827506-24-000010